How often do people stop tirzepatide because of side effects?

What SURMOUNT-1 actually found about discontinuation

The SURMOUNT-1 trial, published in the New England Journal of Medicine, followed 2,539 adults with obesity over 72 weeks. Across all tirzepatide doses, roughly 6–7% of participants discontinued because of adverse events, compared with around 2–3% in the placebo group. The overwhelming majority of those stopping cited gastrointestinal effects: nausea, vomiting, and diarrhoea were among the most frequently reported reasons for stopping.

There is a common misconception that most people who start tirzepatide end up giving it up because they feel terrible. The actual picture is considerably more encouraging. A completion rate above 90% across a 72-week study is not what you would expect from a medicine that routinely causes intolerable side effects. That said, GI symptoms are real, and for a small number of people they are significant enough to outweigh the benefits, which is exactly why honest pre-treatment discussion matters.

The rate did differ slightly by dose: participants escalated to higher strengths tended to see slightly higher rates of GI-related discontinuation, which reflects the dose-dependent nature of these effects. Titration (starting at a low dose and moving up gradually) exists precisely to reduce this burden.

When side effects tend to be worst, and why they often settle

For most people, side effects peak in the few days after the very first injection or after moving up a dose, then ease. This mirrors what NHS guidance on tirzepatide describes: nausea, indigestion, constipation, and loose stools are the most commonly reported, and are generally mild to moderate in severity. Fatigue and headache are reported less often but do occur.

Eating smaller meals, avoiding rich or fatty foods, staying well hydrated, and not lying down immediately after eating can help ease GI discomfort during the adjustment period. A prescriber can also discuss the timing of injections and whether slowing the titration schedule is appropriate, that flexibility often makes the difference between someone persisting and someone stopping early.

For anything affecting your daily life significantly, speaking to your prescribing team is the right step. Our overview of tirzepatide side effects covers the full range in more detail, including what tends to resolve on its own and what warrants a clinical conversation.

When to get medical help without delay

A small number of side effects require prompt attention rather than watchful waiting. Following the MHRA's January 2026 Drug Safety Update, acute pancreatitis is now specifically flagged as an infrequent but potentially serious risk with GLP-1 medicines including tirzepatide. Seek urgent medical help if you develop severe, persistent stomach pain (particularly pain that radiates into your back) with or without vomiting. Do not wait for it to pass on its own.

Other situations that need prompt assessment include signs of a serious allergic reaction (swelling of the face, throat or tongue; difficulty breathing), symptoms of severe dehydration from prolonged vomiting or diarrhoea, gallbladder pain, or any new or worsening low mood, which is among the tirzepatide side effects worth discussing with a clinician promptly. If you are concerned about a side effect during treatment, you can reach our team through our aftercare support line, which is available seven days a week. For emergencies, call 999 or go to your nearest A&E.

If you experience a side effect you think may be linked to tirzepatide, please report it through the Yellow Card scheme. It takes only a few minutes and contributes to the national picture of how medicines behave in real-world use, it is genuinely useful.

How this informs the decision to start treatment

Understanding the discontinuation rate is only part of the picture. The more useful question is: what can be done to keep it as low as possible for you specifically? That starts before the first pen is ever dispensed. A thorough clinical review (covering your health history, existing medicines, and any concerns about the side effects tirzepatide can cause) shapes the titration approach from the beginning. Our clinical team reviews every consultation personally; no algorithm decides your suitability or your starting plan.

People who have previously tried tirzepatide through another provider and stopped because of side effects sometimes transfer to us wanting to try again, usually with a slower escalation. That is a conversation worth having. You can also read about how Mounjaro's side effects compare in practice, or explore what weight-loss treatment options might suit your circumstances. If you have already decided you want to talk it through with a prescriber, check your eligibility and start a free consultation, our prescribers take time to go through side-effect likelihood and what to watch for before any prescription is issued.